NDC 50090-0896

Gabapentin

Gabapentin

Gabapentin is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Gabapentin.

Product ID50090-0896_015d1a9a-ce68-4289-b27e-b1b462b5574f
NDC50090-0896
Product TypeHuman Prescription Drug
Proprietary NameGabapentin
Generic NameGabapentin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2011-01-29
Marketing CategoryANDA / ANDA
Application NumberANDA090858
Labeler NameA-S Medication Solutions
Substance NameGABAPENTIN
Active Ingredient Strength300 mg/1
Pharm ClassesAnti-epileptic
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 50090-0896-0

100 CAPSULE in 1 BOTTLE (50090-0896-0)
Marketing Start Date2014-11-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50090-0896-5 [50090089605]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0896-4 [50090089604]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0896-3 [50090089603]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0896-7 [50090089607]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-07

NDC 50090-0896-1 [50090089601]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0896-6 [50090089606]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-10-24

NDC 50090-0896-2 [50090089602]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

NDC 50090-0896-0 [50090089600]

Gabapentin CAPSULE
Marketing CategoryANDA
Application NumberANDA090858
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-11-28

Drug Details

Active Ingredients

IngredientStrength
GABAPENTIN300 mg/1

Pharmacological Class

  • Anti-epileptic Agent [EPC]
  • Decreased Central Nervous System Disorganized Electrical Activity [PE]

NDC Crossover Matching brand name "Gabapentin" or generic name "Gabapentin"

NDCBrand NameGeneric Name
0093-4443GabapentinGabapentin
0093-4444GabapentinGabapentin
0143-3991GabapentinGabapentin
0143-3993GabapentinGabapentin
0143-3994GabapentinGabapentin
0143-9992GabapentinGabapentin
0143-9993GabapentinGabapentin
0143-9994GabapentinGabapentin
67877-222GabapentinGabapentin
67877-223GabapentinGabapentin
67877-224GabapentinGabapentin
67877-428GabapentinGabapentin
67877-429GabapentinGabapentin
68001-006GabapentinGabapentin
68001-007GabapentinGabapentin
68071-1212GABAPENTINGABAPENTIN
68071-1292GabapentinGabapentin
68071-1808GABAPENTINGABAPENTIN
68071-1907GABAPENTINGABAPENTIN
68071-1995GabapentinGabapentin
68071-3230GABAPENTINGABAPENTIN
68071-3046GabapentinGabapentin
68071-3244GabapentinGabapentin
68071-4087GabapentinGabapentin
68071-3086GABAPENTINGABAPENTIN
68071-3383GABAPENTINGABAPENTIN
68071-3314GABAPENTINGABAPENTIN
68071-4049GABAPENTINGABAPENTIN
68071-4241GABAPENTINGABAPENTIN
68071-4099GabapentinGabapentin
68071-4113GabapentinGabapentin
68071-4292GabapentinGabapentin
68071-4180GabapentinGabapentin
68071-4090GabapentinGabapentin
68071-4329GabapentinGabapentin
68071-4603GabapentinGabapentin
68071-4169GabapentinGabapentin
68071-4346GabapentinGabapentin
68071-4366GabapentinGabapentin
68071-4729GabapentinGabapentin
68071-4402GABAPENTINGABAPENTIN
68071-4784GABAPENTINGABAPENTIN
68084-774GabapentinGabapentin
68084-783GabapentinGabapentin
68084-797GabapentinGabapentin
68084-762GabapentinGabapentin
0440-5562GABAPENTINGABAPENTIN
0440-5563GABAPENTINGABAPENTIN
68084-802GabapentinGabapentin
68151-1028GabapentinGabapentin
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.